drugset / Trial / NCT01447017

A Study of DPK-060 to Investigate Clinical Safety and Efficacy in Patients With Acute External Otitis

NCT01447017 ↗

Phase 2 Completed 69 enrolled DermaGen AB Pergamum AB · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate safety and tolerability of DPK-060 2% ear drops compared to placebo for DPK-060 ear drops in patients with acute external otitis. The secondary objectives are to evaluate clinical cure and microbiological growth following treatment with DPK-060 2% ear drops compared to placebo for DPK-060 ear drops.

Timeline

Start
2011-11
Primary completion
2012-10
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject DPK-060 Unknown 2 % Other

Indications